Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: A case report

Dermatology

Volumn 215, Issue 3, 2007, Pages 229-232

  Monari, P ^a   Farisoglio, C ^a   Calzavara Pinton, P G ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Antibiotic therapy; Borrelia burgdorferi; Cutaneous B cell lymphoma

Indexed keywords

DOXYCYCLINE; TETRACYCLINE;

AGED; ANTIBIOTIC THERAPY; ARTICLE; B CELL LYMPHOMA; BORRELIA BURGDORFERI; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SEROLOGY; SKIN BIOPSY; SKIN LYMPHOMA; SKIN NODULE; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; AGED; ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI; DNA, BACTERIAL; DOXYCYCLINE; HUMANS; LYME DISEASE; LYMPHOMA, B-CELL; MALE; SKIN NEOPLASMS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34548481263     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106580     Document Type: Article

References (21)

1. Hovmark A, Asbrink E, Olsson I: The spirochetal etiology of lymphadenosis benigna cutis solitara. Acta Derm Venereol 1986;66:479-484.
2. Mitchell PD, Reed KD, Vandermause MF, Melinski JW: Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans. Am J Clin Pathol 1993;99:104-107.
3. Ashbrink E, Hovmark H: Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Acta Pathol Microbiol Immunol Scand 1985;93:161-163.
4. Weber K, Wilske B: Mini erythema migrans: a sign of early Lyme borreliosis. Dermatology 2006;212:113-116.
5. Aberer E, Kahofer P, Binder B, Kinaciyan T, Schauperl H, Berghold A: Comparison of two- or three-week regimen and a review of treatment of erythema migrans with phenoxymethylpenicillin. Dermatology 2006;212:160-167.
6. Cerroni L, Zochling N, Putz B, Kerl H: Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997;24:457-461.
7. Goodlad JR, Davidson MM, Hollowood K, Batstone P, Ho-Yen DO: Borrelia burgdorferi-associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi-associated B-cell proliferation in the skin. Histopathology 2000;37:501-508.
8. Garbe C, Stein H, Dienemann D, Orfanos CE: Borrelia burgdorferi-associated cutaneous B-cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991;24:584-590.
9. Goodlad JR, Davidson MM, Hollowood K, Ling C, MacKenzie C, Christie I, Batstone PJ, Ho-Yen DO: Primary cutaneous B-cell lymphoma and Borrelia burgdorferi Infection in patients from the Highlands of Scotland. Am J Pathol 2000;24:1279-1285.
10. Kutting B, Bonsmann G, Metze D, Luger TA, Cerroni L: Borrelia burgdorferi-associated primary cutaneous B-cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 1997;36:311-314.
11. Rijlaarsdam JU, van der Putte SC, Berti E, Kerl H, Rieger E, Toonstra J, Geerts ML, Meijer CJ, Willemze R: Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology 1993;23:119-125.
12. Schmid U, Eckert F, Griesser H, Steinke C, Cogliatti SB, Kaudewitz P, Lennert K: Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells: a clinicopathologic study of 18 patients. Am J Surg Pathol 1995;19:12-20.
13. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Lee Harris N, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJLM: WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-3785.
14. Torne R, Su WPD, Smolle J, Kerl H: Clinicopathologic study of cutaneous plasmacytoma. Int J Dermatol 1990;29:562-566.
15. Li C, Inagaki H, Kuo TT, Okabe M, Eimoto T: Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases. Am J Surg Pathol 2003;27:1061-1069.
16. Cerroni L, Signoretti S, Hofler G, Annessi G, Putz B, Lackinger E, Metze D, Giannetti A, Kerl H: Primary cutaneous marginal zone Bcell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997;21:1307-1315.
17. Bailey EM, Ferry JA, Harris NL, Mihm MC, Jacobson JO, Ducan LM: Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol 1996;20:1011-1023.
18. Meyer S, Vogt T, Obermann EC, Landthaler M, Karrer S: Cutaneous pseudolymphoma induced by Cimicifuga racemosa. Dermatology 2007;214:94-96.
19. Santino I, Dastoli F, Sessa R, Del Piano M. Geographical incidence of infection with Borrelia burgdorferi in Europe. Panminerva Med 1997;39:208-214.
20. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG: Regression of primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577.
21. Roggero E, Zucca E, Mainetti C, Bretoni F, Valsangiacomo C, Pedrinis E, Borisch B, Piffaretti JC, Cavalli F, Isaacson PG: Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000;31:263-268.